Scott Schachter
Optometrist · Pismo Beach, CANPI 1447230602
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2019 at $203,578 and has fallen 97.9% since, to $4,250 in 2022. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 496 payments — averaging $628.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$73K
- Novartis$47K
- Sun Pharmaceutical Industries Inc.$47K
- AbbVie$35K
- Sight Sciences, Inc.$29K
- Lumenis, Inc$22K
- plus $59K from 10 others
Across 3 payments — averaging $14,307 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dompe US, Inc.$38K
- Novartis$5K
What the payments were for
- Consulting fees$104,10233%
- Speaking & faculty fees$152,69549%
- Travel & lodging$41,86213%
- Food & beverage$13,1724%
- Education$210%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 196 | $73,126 |
| Novartis | 68 | $46,988 |
| Sun Pharmaceutical Industries Inc. | 57 | $46,712 |
| AbbVie | 47 | $34,917 |
| Sight Sciences, Inc. | 36 | $28,594 |
| Lumenis, Inc | 2 | $22,071 |
| Maculogix, Inc. | 18 | $19,056 |
| Kala Pharmaceuticals, Inc. | 26 | $18,073 |
| Dompe US, Inc. | 17 | $11,347 |
| Alcon | 16 | $8,543 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $1,461 |
| Vertical Pharmaceuticals, LLC | 1 | $543 |
| Coopervision Inc. | 2 | $189 |
| Alcon Research LLC | 2 | $184 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $47 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIIDRA$101,075
- CEQUA$45,923
- TearCare$27,616
- AdaptDx$18,609
- EYSUVIS$16,646
- Oxervate$11,034
- RESTASIS MULTIDOSE$10,616
- RESTASIS$7,139
- DAILIES$4,940
- Systane$2,054
- INFUSE$1,200
- ILUX$1,060
- LUMIGAN$800
- COMBIGAN$800
- INVELTYS$500
- TearCare SmartLid$500
- TEARCARE(TM) (2.2) SYSTEM KIT$500
- AcrySof IQ PanOptix$135
- BIOTRUE$121
- ULTRA$121
How this compares
$311,871 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Other optometrist in Pismo Beach
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
- Katie ChuRosemead$271K
- Heidi PhamSacramento$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.